Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in rats
Lakhwinder Singh1, Surbhi Rana2, Sidharth Mehan3
1Head Department of Applied Science CGC College of Engineering Landran, Punjab, India.
Abstract:
The present study aimed to investigate the role of adenylyl cyclase activator in preventing diabetic nephropathy in rats. Renal function parameters, renal hypertrophy, lipid profile, markers of oxidative stress and free radical scavenging activities were assessed. Histopathology was performed to confirm Streptozotocin induced renal morphological changes in diabetic rats. Male Wistar rats were used in the present study to reduce the effect of estrogen. Rats were subjected to high fat diet (HFD) for two weeks followed by low dose of Streptozotocin (STZ) [35 mg/kg, i.p.] to develop experimental diabetic nephropathy in eight weeks. Two weeks treatment with low dose of Forskolin (10 mg/kg) reduced the level of diabetic nephropathy markers but results observed were not significant. Whereas, Forskolin intermediate dose (20 mg/kg) and high dose (30 mg/kg) treated rats significantly attenuated diabetes induced elevated renal function parameters and endogenous antioxidants enzymatic activities. High dose of Forskolin was found to be more effective in attenuating the renal structural and functional abnormalities. Forskolin prevented renal structural and functional abnormalities in diabetic rats. Histopathological evaluation revealed that Forskolin (20 mg/kg and 30 mg/kg) treated diabetic rats demonstrated reduced vacuolar degeneration of tubules and glomerulosclerosis. In the present study, Glibenclamide (0.6 mg/kg) and Atorvastatin (0.5 mg/kg) were used as standard drugs. Our results demonstrated synergistic effects, when high dose of Forskolin was co-administered with standard drugs. In conclusion, treatment with adenylyl cyclase activator, Forskolin in diabetic rats reduced the elevated serum glucose level, biomarkers of renal morphological dysfunction, renal hypertrophy, dyslipidaemia, oxidative stress and improved renal structure, function and enhanced level of endogenous antioxidants. Forskolin has a potential to prevent nephropathy without showing any effect on body weight in diabetic rats.
Insights
Forskolin, an adenylyl cyclase activator, shows potential in preventing diabetic nephropathy in rats. High doses significantly improved kidney function and structure, offering a promising therapeutic avenue.
Area of Science:
- Pharmacology
- Nephrology
- Biochemistry
Background:
- Diabetic nephropathy is a major complication of diabetes mellitus.
- Identifying effective treatments to prevent kidney damage is crucial.
Purpose of the Study:
- To investigate the protective role of the adenylyl cyclase activator, Forskolin, against diabetic nephropathy in a rat model.
- To assess Forskolin's effects on renal function, oxidative stress, and histological changes.
Main Methods:
- Experimental diabetic nephropathy was induced in male Wistar rats using a high-fat diet and streptozotocin.
- Rats were treated with varying doses of Forskolin, Glibenclamide, or Atorvastatin.
- Renal function, lipid profile, oxidative stress markers, and histopathology were evaluated.
Main Results:
- Forskolin at intermediate (20 mg/kg) and high (30 mg/kg) doses significantly attenuated diabetes-induced increases in renal function parameters and oxidative stress.
- High-dose Forskolin treatment reduced vacuolar degeneration of tubules and glomerulosclerosis.
- Synergistic effects were observed when Forskolin was co-administered with standard drugs.
Conclusions:
- Forskolin effectively prevents renal structural and functional abnormalities in diabetic rats.
- It reduces hyperglycemia, renal dysfunction biomarkers, hypertrophy, dyslipidemia, and oxidative stress.
- Forskolin demonstrates potential for preventing diabetic nephropathy without affecting body weight.
More Related Videos
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture